{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:55:56Z","timestamp":1794210956300,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Resistance to antibiotics is approaching crisis levels for organisms such as the ESKAPEE pathogens (includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp., and Escherichia coli) that often are acquired in hospitals. These organisms sometimes have acquired plasmids that confer resistance to most if not all beta-lactam antibiotics. We have been developing alternative means for dealing with antibiotic resistant microbes that cause infections in humans by developing viruses (bacteriophages) that attack and kill them. One of these pathogens, K. pneumoniae, has one of the highest propensities for antimicrobial resistance. We identified many phages that have lytic capacity against limited numbers of clinical isolates, and through experimental evolution over the course of 30 days, were able to vastly expand the host ranges of these phages to kill a broader range of clinical K. pneumoniae isolates including MDR (multi-drug resistant) and XDR (extensively-drug resistant) isolates. Most interestingly, they were capable of inhibiting growth of clinical isolates both on solid and in liquid medium over extended periods. That we were able to extend the host ranges of multiple na\u00efve antibiotic resistant\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    through experimental phage evolution suggests that such a technique may be applicable to other antibiotic-resistant organisms to help stem the tide of antibiotic resistance and offer further options for medical treatments.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-66062-7","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:02:50Z","timestamp":1763546570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Experimental phage evolution results in expanded host ranges against antibiotic resistant Klebsiella pneumoniae isolates"],"prefix":"10.1038","volume":"16","author":[{"given":"Pooja","family":"Ghatbale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Devequi","family":"Gomes Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hitchcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-9663","authenticated-orcid":false,"given":"Job","family":"Shiach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bardar\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrabali","family":"Ghose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5423-6014","authenticated-orcid":false,"given":"Katrine L.","family":"Whiteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-8426","authenticated-orcid":false,"given":"Robert T.","family":"Schooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Richard Allen","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana G.","family":"Cobi\u00e1n G\u00fcemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-8452","authenticated-orcid":false,"given":"Justin R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Pride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"66062_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12992-023-00930-z","volume":"19","author":"YA Adebisi","year":"2023","unstructured":"Adebisi, Y. A. Balancing the risks and benefits of antibiotic use in a globalized world: the ethics of antimicrobial resistance. Glob. Health 19, 27 (2023).","journal-title":"Glob. Health"},{"key":"66062_CR2","doi-asserted-by":"publisher","first-page":"1403168","DOI":"10.3389\/fmicb.2024.1403168","volume":"15","author":"S Sharma","year":"2024","unstructured":"Sharma, S. et al. Emerging challenges in antimicrobial resistance: implications for pathogenic microorganisms, novel antibiotics, and their impact on sustainability. Front. Microbiol. 15, 1403168 (2024).","journal-title":"Front. Microbiol."},{"key":"66062_CR3","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.2147\/IDR.S428837","volume":"16","author":"H Endale","year":"2023","unstructured":"Endale, H., Mathewos, M. & Abdeta, D. Potential causes of spread of antimicrobial resistance and preventive measures in one health perspective-a review. Infect. Drug Resist 16, 7515\u20137545 (2023).","journal-title":"Infect. Drug Resist"},{"key":"66062_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41545-020-0051-0","volume":"3","author":"Y He","year":"2020","unstructured":"He, Y. et al. Antibiotic resistance genes from livestock waste: occurrence, dissemination, and treatment. npj Clean. Water 3, 4 (2020).","journal-title":"npj Clean. Water"},{"key":"66062_CR5","doi-asserted-by":"crossref","unstructured":"Theuretzbacher, U., Evaluating the innovative potential of the global antibacterial pipeline. Clin. Microbiol. Infect. 31, 903\u2013909 (2023).","DOI":"10.1016\/j.cmi.2023.09.024"},{"key":"66062_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee, S. A. et al. Phage therapy: From biological mechanisms to future directions. Cell 186, 17\u201331 (2023).","journal-title":"Cell"},{"key":"66062_CR7","doi-asserted-by":"crossref","unstructured":"Hitchcock, N. M. et al., Current clinical landscape and global potential of bacteriophage therapy. Viruses. 15, 1020 (2023).","DOI":"10.3390\/v15041020"},{"key":"66062_CR8","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","volume":"9","author":"JP Pirnay","year":"2024","unstructured":"Pirnay, J. P. et al. Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study. Nat. Microbiol. 9, 1434\u20131453 (2024).","journal-title":"Nat. Microbiol."},{"key":"66062_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4161\/bact.20757","volume":"2","author":"WC Summers","year":"2012","unstructured":"Summers, W. C. The strange history of phage therapy. Bacteriophage 2, 130\u2013133 (2012).","journal-title":"Bacteriophage"},{"key":"66062_CR10","doi-asserted-by":"crossref","unstructured":"Kaminski, B. & J. Paczesny, Bacteriophage challenges in industrial processes: a historical unveiling and future outlook. Pathogens 13, 152, (2024).","DOI":"10.3390\/pathogens13020152"},{"key":"66062_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-virology-012423-110530","volume":"10","author":"A Oromi-Bosch","year":"2023","unstructured":"Oromi-Bosch, A., Antani, J. D. & Turner, P. E. Developing phage therapy that overcomes the evolution of bacterial resistance. Annu. Rev. Virol. 10, 503\u2013524 (2023).","journal-title":"Annu. Rev. Virol."},{"key":"66062_CR12","doi-asserted-by":"crossref","unstructured":"Kushwaha, S. O. et al., Bacteriophages as a potential substitute for antibiotics: a comprehensive review. Cell Biochem. Funct. 42, e4022 (2024).","DOI":"10.1002\/cbf.4022"},{"key":"66062_CR13","unstructured":"WHO Bacterial Priority Pathogens List 2024 Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance. (World Health Organization, 2024)."},{"key":"66062_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07678-8","volume":"22","author":"S Ruekit","year":"2022","unstructured":"Ruekit, S. et al. Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017\u20132018). BMC Infect. Dis. 22, 695 (2022).","journal-title":"BMC Infect. Dis."},{"key":"66062_CR15","doi-asserted-by":"publisher","unstructured":"Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother. 61. https:\/\/doi.org\/10.1128\/aac.00954-17 (2017).","DOI":"10.1128\/aac.00954-17"},{"key":"66062_CR16","doi-asserted-by":"publisher","first-page":"e0065423","DOI":"10.1128\/aac.00654-23","volume":"67","author":"AG Cobian Guemes","year":"2023","unstructured":"Cobian Guemes, A. G. et al. Jumbo phages are active against extensively drug-resistant eyedrop-associated Pseudomonas aeruginosa infections. Antimicrob. Agents Chemother. 67, e0065423 (2023).","journal-title":"Antimicrob. Agents Chemother."},{"key":"66062_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.adi5536","volume":"382","author":"JM Borin","year":"2023","unstructured":"Borin, J. M. et al. Rapid bacteria-phage coevolution drives the emergence of multiscale networks. Science 382, 674\u2013678 (2023).","journal-title":"Science"},{"key":"66062_CR18","doi-asserted-by":"crossref","unstructured":"Laanto, E. et al., Adapting a phage to combat phage resistance. Antibiotics 9, 291 (2020).","DOI":"10.3390\/antibiotics9060291"},{"key":"66062_CR19","doi-asserted-by":"crossref","unstructured":"Peters, T. L. et al. Mutant and recombinant phages selected from in vitro coevolution conditions overcome phage-resistant Listeria monocytogenes. Appl. Environ. Microbiol. 86, e02138\u201320 (2020).","DOI":"10.1128\/AEM.02138-20"},{"key":"66062_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/jeb.12774","volume":"29","author":"VP Friman","year":"2016","unstructured":"Friman, V. P. et al. Pre-adapting parasitic phages to a pathogen leads to increased pathogen clearance and lowered resistance evolution with Pseudomonas aeruginosa cystic fibrosis bacterial isolates. J. Evol. Biol. 29, 188\u2013198 (2016).","journal-title":"J. Evol. Biol."},{"key":"66062_CR21","doi-asserted-by":"crossref","unstructured":"Monferrer, E. & P. Domingo-Calap. Virus-host coevolution as a tool for controlling bacterial resistance to phage therapy. J. Biotechnol. Biomed. 2, 96\u2013104 (2019).","DOI":"10.26502\/jbb.2642-91280013"},{"key":"66062_CR22","doi-asserted-by":"publisher","first-page":"ycae082","DOI":"10.1093\/ismeco\/ycae082","volume":"4","author":"L Ngiam","year":"2024","unstructured":"Ngiam, L., Weynberg, K. & Guo, J. Evolutionary and co-evolutionary phage training approaches enhance bacterial suppression and delay the emergence of phage resistance. ISME Commun. 4, ycae082 (2024).","journal-title":"ISME Commun."},{"key":"66062_CR23","doi-asserted-by":"publisher","first-page":"104032","DOI":"10.1016\/j.sjbs.2024.104032","volume":"31","author":"G Alotaibi","year":"2024","unstructured":"Alotaibi, G. Prevalence, pandemic, preventions and policies to overcome antimicrobial resistance. Saudi J. Biol. Sci. 31, 104032 (2024).","journal-title":"Saudi J. Biol. Sci."},{"key":"66062_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.it.2023.08.005","volume":"44","author":"PL Wantuch","year":"2023","unstructured":"Wantuch, P. L. & Rosen, D. A. Klebsiella pneumoniae: adaptive immune landscapes and vaccine horizons. Trends Immunol. 44, 826\u2013844 (2023).","journal-title":"Trends Immunol."},{"key":"66062_CR25","first-page":"51","volume":"130","author":"V Vernet","year":"1995","unstructured":"Vernet, V. et al. Virulence factors (aerobactin and mucoid phenotype) in Klebsiella pneumoniae and Escherichia coli blood culture isolates. FEMS Microbiol. Lett. 130, 51\u201357 (1995).","journal-title":"FEMS Microbiol. Lett."},{"key":"66062_CR26","doi-asserted-by":"publisher","first-page":"106467","DOI":"10.1016\/j.micpath.2023.106467","volume":"186","author":"M Kulshrestha","year":"2024","unstructured":"Kulshrestha, M., Tiwari, M. & Tiwari, V. Bacteriophage therapy against ESKAPE bacterial pathogens: current status, strategies, challenges, and future scope. Micro Pathog. 186, 106467 (2024).","journal-title":"Micro Pathog."},{"key":"66062_CR27","doi-asserted-by":"publisher","first-page":"107221","DOI":"10.1016\/j.ijantimicag.2024.107221","volume":"64","author":"Q Chen","year":"2024","unstructured":"Chen, Q. et al. Bacteriophage-resistant carbapenem-resistant Klebsiella pneumoniae shows reduced antibiotic resistance and virulence. Int. J. Antimicrob. Agents 64, 107221 (2024).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"66062_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/eva.13518","volume":"16","author":"JM Borin","year":"2023","unstructured":"Borin, J. M. et al. Comparison of bacterial suppression by phage cocktails, dual-receptor generalists, and coevolutionarily trained phages. Evol. Appl. 16, 152\u2013162 (2023).","journal-title":"Evol. Appl."},{"key":"66062_CR29","doi-asserted-by":"crossref","unstructured":"Ombelet, S. et al. Evaluation of MicroScan bacterial identification panels for low-resource settings. Diagnostics 11, 349 (2021).","DOI":"10.3390\/diagnostics11020349"},{"key":"66062_CR30","doi-asserted-by":"publisher","first-page":"e0001922","DOI":"10.1128\/msystems.00019-22","volume":"7","author":"S Wandro","year":"2022","unstructured":"Wandro, S. et al. Phage cocktails constrain the growth of Enterococcus. mSystems 7, e0001922 (2022).","journal-title":"mSystems"},{"key":"66062_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60327-164-6_7","volume":"501","author":"AM Kropinski","year":"2009","unstructured":"Kropinski, A. M. et al. Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol. Biol. 501, 69\u201376 (2009).","journal-title":"Methods Mol. Biol."},{"key":"66062_CR32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41587-020-00774-7","volume":"39","author":"S Nayfach","year":"2021","unstructured":"Nayfach, S. et al. CheckV assesses the quality and completeness of metagenome-assembled viral genomes. Nat. Biotechnol. 39, 578\u2013585 (2021).","journal-title":"Nat. Biotechnol."},{"key":"66062_CR33","doi-asserted-by":"crossref","unstructured":"Figueroa Iii, J. L. et al. MetaCerberus: distributed highly parallelized HMM-based processing for robust functional annotation across the tree of life. Bioinformatics, 40, btae119 (2024).","DOI":"10.1093\/bioinformatics\/btae119"},{"key":"66062_CR34","doi-asserted-by":"crossref","unstructured":"Larralde, M., Pyrodigal: Python bindings and interface to Prodigal, an efficient method for gene prediction in prokaryotes. J. Open Source Softw. 4296 (2022).","DOI":"10.21105\/joss.04296"},{"key":"66062_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/s41587-023-01953-y","volume":"42","author":"AP Camargo","year":"2024","unstructured":"Camargo, A. P. et al. Identification of mobile genetic elements with geNomad. Nat. Biotechnol. 42, 1303\u20131312 (2024).","journal-title":"Nat. Biotechnol."},{"key":"66062_CR36","doi-asserted-by":"crossref","unstructured":"Cobian Guemes, A. G. et al. Compounding Achromobacter phages for therapeutic applications. Viruses, 15, 1665 (2023).","DOI":"10.3390\/v15081665"},{"key":"66062_CR37","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1093\/bioinformatics\/btx157","volume":"33","author":"Y Nishimura","year":"2017","unstructured":"Nishimura, Y. et al. ViPTree: the viral proteomic tree server. Bioinformatics 33, 2379\u20132380 (2017).","journal-title":"Bioinformatics"},{"key":"66062_CR38","doi-asserted-by":"crossref","unstructured":"Nishimura, Y. et al. DiGAlign: versatile and interactive visualization of sequence alignment for comparative genomics. Microbes Environ. 39, (2024).","DOI":"10.1264\/jsme2.ME23061"},{"key":"66062_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"66062_CR40","doi-asserted-by":"crossref","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience, 10, giab008 (2021).","DOI":"10.1093\/gigascience\/giab008"},{"key":"66062_CR41","doi-asserted-by":"publisher","first-page":"D678","DOI":"10.1093\/nar\/gkac1003","volume":"51","author":"RD Olson","year":"2023","unstructured":"Olson, R. D. et al. Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): a resource combining PATRIC, IRD and ViPR. Nucleic Acids Res. 51, D678\u2013D689 (2023).","journal-title":"Nucleic Acids Res."},{"key":"66062_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/70570","volume":"23","author":"GT Marth","year":"1999","unstructured":"Marth, G. T. et al. A general approach to single-nucleotide polymorphism discovery. Nat. Genet 23, 452\u2013456 (1999).","journal-title":"Nat. Genet"},{"key":"66062_CR43","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/bioinformatics\/btw069","volume":"32","author":"NH Freese","year":"2016","unstructured":"Freese, N. H., Norris, D. C. & Loraine, A. E. Integrated genome browser: visual analytics platform for genomics. Bioinformatics 32, 2089\u20132095 (2016).","journal-title":"Bioinformatics"},{"key":"66062_CR44","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s10482-017-0844-4","volume":"110","author":"SH Yoon","year":"2017","unstructured":"Yoon, S. H. et al. A large-scale evaluation of algorithms to calculate average nucleotide identity. Antonie Van. Leeuwenhoek 110, 1281\u20131286 (2017).","journal-title":"Antonie Van. Leeuwenhoek"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66062-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66062-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:02:54Z","timestamp":1763546574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66062-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66062"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66062-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest. R.A.W. III is the CEO of RAW Molecular Systems (RAW), LLC, but no financial, IP, or others from RAW LLC were used or contributed to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9903"}}